Monday, June 29, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $283.78 +3.14%
MSFT $372.97 +5.71%
GOOGL $337.39 -1.84%
AMZN $232.69 +2.50%
TSLA $379.71 +1.22%
META $550.25 +1.36%
NVDA $192.53 -1.64%
JPM $329.05 -1.81%
BTC $26.39 +0.80%
ETH $14.96 +1.08%
AAPL
$283.78
▲ 3.14%
MSFT
$372.97
▲ 5.71%
GOOGL
$337.39
▼ 1.84%
AMZN
$232.69
▲ 2.50%
TSLA
$379.71
▲ 1.22%
META
$550.25
▲ 1.36%
NVDA
$192.53
▼ 1.64%
JPM
$329.05
▼ 1.81%
All Markets Technology Economy Science Health Sports Entertainment Politics
Bloomberg Markets
UniQure Shares Soar After FDA Reversal on Its Huntington’s Therapy
UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the Trump administration is relaxing its previous hard-line stance on drug reviews.
business  Jun 17, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free